18. Thyme
The respiratory herb — thymol, EMA-approved cough syrup, and the Bronchipret evidence.
Thyme in 1 minute
What does it provide? Thymol (40–60% of essential oil), carvacrol, p-cymene, and rosmarinic acid — respiratory expectorant, antimicrobial, antioxidant, with moderate antispasmodic activity.
How much? In the kitchen 1–3 g fresh or dried leaf (≈ 1–2 tsp) daily; for clinical use (cough) syrup or tea (EMA), 1–4 g/day.
When to avoid? Pregnancy with high-dose essential oil, concentrated essential oil on infants, Lamiaceae allergy, severe hypothyroidism (theoretical), high-dose alongside anticoagulants.
Thyme (Thymus vulgaris) is native to the western Mediterranean and held a central role in both Greek-Roman cuisine and medicine. Its name comes from the Greek "thymos" ("courage"), and classical Greek soldiers took thyme baths before battle for strength. Hippocrates and Pliny recommended it for respiratory complaints, digestion, and topical wounds. It was a main ingredient of the classical Egyptian embalming ritual — thyme's antimicrobial effect has been known empirically for a very long time.
In medieval European monastery gardens (Hildegard von Bingen, Salerno school), thyme topped the list of respiratory herbs — for cough, bronchitis, and asthmatic complaints. It was a component of the 14th-century "aqua Hungarica" alcohol extract. Modern phytochemistry identified thymol in 1719 (Caspar Neumann), and from the late 19th century thymol-containing syrups (Hustagil, Bronchicum) were standard in clinical use.
The 21st century brought robust clinical evidence: the Marzian 2007 RCT confirmed the efficacy of Bronchipret (thyme + English ivy leaf extract) in acute bronchitis. ESCOP and EMA/HMPC monographs recognize thyme extract under "well-established use" for symptomatic treatment of acute bronchitis and cough. This makes thyme one of the respiratory herbs with the best clinical evidence base.[2353]
Scientific Background
Thyme essential oil is 40–60% thymol-dominant, complemented by carvacrol, p-cymene, γ-terpinene, linalool, and β-myrcene. Thymol is a phenolic monoterpenoid with strong antimicrobial (cell-membrane disrupting), antioxidant, and local anesthetic activity.[2356]
The most robust clinical evidence concerns acute bronchitis. The Marzian 2007 RCT showed Bronchipret (thyme + English ivy leaf) had significant expectorant and cough-reducing effects versus placebo.[2355] EMA/HMPC grants "well-established use" status to thyme extract for symptomatic treatment of acute bronchitis and cold in adults and children over 12; under "traditional use" also in children over 4.[2354]
Antimicrobial spectrum (in vitro): thymol and carvacrol are synergistically strong against Gram-positive and Gram-negative bacteria (Staphylococcus, Streptococcus, Listeria, E. coli, Salmonella), Helicobacter pylori, and Candida albicans.[2357] Topical thymol-containing mouthwash (e.g., Listerine) has proven plaque-reducing effects.[2358]
Cough-calming (expectorant) effect: thymol is mucolytic, decreases respiratory secretion viscosity, and stimulates ciliary activity.[2359] The classic "thyme tea with honey" is a home respiratory pattern.
At the microbiome level, thymol selectively reduces opportunistic pathogens in vitro; in vivo human RCT is limited.
Safety: at culinary amounts absolutely safe. In pregnancy, high-dose essential oil should be avoided (uterine-stimulant potential). Concentrated essential oil is not recommended for infants; weak dried-leaf-based tea (EMA: over 4 years) is acceptable in small amounts after medical consultation.
- + Honey, lemon (cough syrup): classic home respiratory pattern.
- + Ivy leaf (Bronchipret synergy): clinically proven expectorant.
- + Olive, lemon (Mediterranean matrix): flavor synergy.
- + Roast potato, lamb, chicken: classic Mediterranean spice.
- + Eucalyptus, silver fir (respiratory inhaler): classic "herbal vapor."
- + Rosemary, oregano, marjoram (Mediterranean mix): basis of "herbes de Provence."
- Anticoagulants + high-dose essential oil: theoretical additive bleeding risk.
- Thyroid hormone (levothyroxine) + high-dose supplement: theoretical suppression.
- Long boiling (30+ min high heat): essential oil evaporates — add at end of cooking.
- Concentrated essential oil on infants: strictly to be avoided.
- With iron: rosmarinic acid may chelate: separate in time.
- Topical unpurified thymol oil on skin: severe contact irritation.
- Pregnancy (high-dose essential oil): uterine-stimulant potential.
- Infants < 2 years concentrated essential oil: respiratory depression risk.
- Lamiaceae allergy (basil, oregano, rosemary): cross-reaction.
- Severe hypothyroidism: theoretical goitrogen activity.
- Active gastric ulcer: concentrated essential oil irritates.
- Severe asthma flare: rare but reported bronchospasm trigger.
- Anticoagulant therapy: high-dose supplement only under medical supervision.
- Undiluted on skin: contact sensitivity.
Daily serving
1–3 g fresh or dried leaf (≈ 1–2 tsp) daily; tea 1–2 g leaf/200 ml water, 10 min standing (EMA).
Preparation pattern
- Fresh leaf: strip leaves from stem; add at end of cooking or frying.
- Dried leaf: crumble and add to food.
- Tea: 1–2 g dried leaf + 200 ml hot water, 10 min covered.
- Cough syrup: strong tea + honey (+ lemon juice), 1 tsp 3–4×/day.
Classic patterns
Central European paprikás potatoes: potato + sausage + paprika + thyme + bay leaf.
Provençal lamb: lamb + rosemary + thyme + garlic + olive oil.
Bouquet garni: thyme + parsley + bay leaf (classic French soup bouquet).
Cough tea: 1 tsp dried thyme + 200 ml hot water, 10 min, honey + lemon juice.
Storage and what not to do
Storage: fresh thyme 1–2 weeks refrigerated; dried 1 year airtight in a dark place.
What not to do: don't apply concentrated essential oil to infants, don't combine a clinical-dose supplement with warfarin on your own, don't overboil at high heat.
References
[2353] . EMA/HMPC 2013. European Union herbal monograph on Thymus vulgaris L., herba. 2013. Link
EMA/HMPC European Union herbal monograph on the herb of Thymus vulgaris L. (thyme, thymi herba).
[2354] Marzian O. Treatment of acute bronchitis in children and adolescents. Non-interventional postmarketing surveillance study confirms the benefit and safety of a syrup made of extracts from thyme and ivy leaves 2007;149(suppl 1):69–74. MMW Fortschr Med. 2007.
Non-interventional postmarketing surveillance study on the treatment of acute bronchitis in children and adolescents with a syrup made of thyme and ivy leaf extracts.
[2355] Kemmerich B et al. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough2006;56(9):652–660. Arzneimittelforschung. Link
STUDY OBJECTIVE: To assess the efficacy and tolerability of a fixed fluid extract combination of thyme and ivy leaves (thyme-ivy combination) and matched placebo in patients suffering from acute bronchitis with productive cough. METHODS: In a double-blind, placebo-controlled, multicentre Phase IV study 361 outpatients with acute bronchitis and > or =10 coughing fits during the day, onset of bronchial mucus production with impaired ability to cough up at a maximum of 2 days prior to recruitment, and a Bronchitis Severity Score (BSS) > or =5 score points were randomly assigned to an 11-day treatment (5.4 ml three times daily) with either thyme-ivy combination syrup (Bronchipret Saft; N=182) or placebo syrup (N=179). After the baseline examination (Visit 1 = Day 0), 2 control examinations were scheduled (Visit 2 = Day 4; Visit 3 = Day 10/end of treatment). The efficacy of study treatment on acute bronchitis was evaluated by the patient's daily counting of coughing fits during the daytime (manual counter), assessment of acute bronchitis related symptoms and by the investigator's assessment of the most important symptoms of acute bronchitis using the BSS. Evaluation of tolerability was based upon adverse event (AE) monitoring, measurement of vital signs as well as the Primary outcome was the change in frequency of coughing fits during daytime on days 7-9 according to patient's accurate daily recording with a manual counter and documentation in the diary. Treatment effects were analysed by analysis of variance (ANOVA) adjusted for centre effects.
[2356] ESCOP. Thymi herba — Thyme 2003. ESCOP Monographs. 2003.
ESCOP monograph on thyme (Thymi herba).
[2357] Burt SA. Essential oils: their antibacterial properties2004. Int J Food Microbiol. Link
Review article on the antibacterial properties of essential oils.
[2358] Sienkiewicz M et al. Antibacterial activity of thyme and lavender essential oils 2011. Med Chem. 2011.
Study on the antibacterial activity of thyme and lavender essential oils.
[2359] Salehi B et al. Thymol, thyme, and other plant sources: health and potential uses2018. Phytother Res. Link
Thymol is a naturally occurring phenol monoterpene derivative of cymene and isomer of carvacrol. Thymol (10-64\%) is one of the major constituent of essential oils of thyme (Thymus vulgaris L., Lamiaceae), a medicinal plant with several therapeutic properties. This plant, native to Mediterranean regions, is commonly used as a culinary herb and also with a long history of use for different medicinal purposes. Nowadays, thymol and thyme present a wide range of functional possibilities in pharmacy, food, and cosmetic industry. The interest in the formulation of pharmaceuticals, nutraceuticals, and cosmeceuticals based on thymol is due to several studies that have evaluated the potential therapeutic uses of this compound for the treatment of disorders affecting the respiratory, nervous, and cardiovascular systems. Moreover, this compound also exhibits antimicrobial, antioxidant, anticarcinogenesis, anti-inflammatory, and antispasmodic activities, as well as a potential as a growth enhancer and immunomodulator.